Adams Helen C. 4
4 · Immix Biopharma, Inc. · Filed Jul 18, 2022
Insider Transaction Report
Form 4
Adams Helen C.
Director
Transactions
- Award
Stock Options
2022-07-14+16,000→ 53,500 totalExercise: $2.64Exp: 2032-07-14→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]Options vest monthly over 12 months from date of grant.